TGTX Dividend History & Analysis | N/A Yield
TGTX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 390,557 M | 3.34% | 7.54% |
| AMGN | 183,880 M | 3.21% | 5.93% |
| GILD | 176,133 M | 2.79% | 5.63% |
| HLN | 46,623 M | 1.76% | 2.46% |
| BIM | 13,627 M | 0.74% | 0.75% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,425 M | 134% | 95.6% |
| HLN | 46,623 M | 30.1% | 100% |
| AMGN | 183,880 M | 7.84% | 100% |
| BIM | 13,627 M | 9.76% | 96.0% |
| ABBV | 390,557 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.21% Yield
2.79% Yield
TGTX Dividend History: as of February 2026
No dividends paid yet.TGTX Dividend FAQ
TG Therapeutics, Inc. (NASDAQ:TGTX) is a commercial-stage biopharmaceutical firm that develops and markets novel B-cell-targeted therapies, primarily for multiple sclerosis (MS) and other B-cell-mediated diseases. Its flagship product, BRIUMVI (ublituximab), is an anti-CD20 monoclonal antibody approved for adult patients with relapsing forms of MS, including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. The pipeline includes a next-generation IV formulation of ublituximab, an oral BTK inhibitor (TG-1701), and a bispecific CD47/CD19 antibody (TG-1801), supported by multiple licensing and collaboration agreements with partners such as LFB, GTC, Jiangsu Hengrui, and Checkpoint Therapeutics.
What is the Dividend Yield of TGTX?
As of February 2026, TGTX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 29.12.Does TGTX pay a dividend?
As of February 2026 TGTX does not pay a dividend.How often does TGTX pay dividends?
Over the last 12 months, TGTX has issued dividend payments.TGTX dividend forecast
Based on historical data, the forecasted dividends per share for TGTX for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will TGTX pay dividends in 2026?
The next Ex-Dividend date for TG Therapeutics (TGTX) is currently unknown.What is the next Ex-Dividend Date for TGTX?
The next Ex-Dividend date for TG Therapeutics (TGTX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of TGTX?
TGTX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of TGTX?
TGTX's 5-Year Yield on Cost is -%. If you bought TGTX's shares at 52.43 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of TGTX?
TGTX Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does TGTX have a good Dividend Yield?
TGTX`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of TGTX?
The Dividend Payout Ratio of TGTX is unknown.What is the Dividend Rating of TGTX?
TGTX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-02-01 02:19